In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 8th, 2004 | 27 | Yes |
Popular Name: Gatifloxacin Gatifloxacin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 112811-59-3 , 160738-57-8 , 180200-66-2 , 316819-28-0 , 316819-33-7 , [112811-59-3] , [160738-57-8] , [180200-66-2]
1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-8-methoxy-7-[(3R)-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid
112811-59-3; AM 1155; C07661; Gatifloxacin
160738-57-8; D08011; Gatifloxacin (INN); Gatifloxacin (TN); Zymer (TN)
CPD000043336; Gatifloxacin; SAM002589955
CYCLOPROPYLFLUOROMETHOXYMETHYLPIPERAZINYLOXODIHYDROQUINOLINECARBOXYLI
CYCLOPROPYLFLUOROMETHOXYMETHYLPIPERAZINYLOXODIHYDROQUINOLINECARBOXYLICACIDSESQUIHYDRAT
Gatiflo,Tequin and Zymar, Gatifloxacin
Gatifloxacin & Gamma Interferon
gatifloxacin; gatifloxacine; gatifloxacino; gatifloxacinum
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.04 | 8.97 | -101.63 | 2 | 7 | 0 | 91 | 375.4 | 4 | ↓ |
Hi High (pH 8-9.5) | -0.04 | 7.73 | -63.01 | 1 | 7 | -1 | 87 | 374.392 | 4 | ↓ |
Mid Mid (pH 6-8) | -2.78 | 7.72 | -78.04 | 3 | 7 | 1 | 94 | 376.408 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 2.658 | Bitter DB |
ALOGPS_SOLUBILITY | 6.31e-01 g/l | DrugBank-approved |
Purity | 95+% | Matrix Scientific |
biological_use | Antibacterial | IBScreen Bioactives IBScreen Bioactives |
biological_use | Antibiotic | IBScreen Bioactives |
mechanism | Inhibits the bacterial enzymes DNA gyrase and topoisomerase IV | IBScreen Bioactives |
Warnings | IRRITANT | Matrix Scientific |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : G-1213; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: G-1213; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |
Target | Topoisomerase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNH2-1-E | HERG (cluster #1 Of 5), Eukaryotic | Eukaryotes | 3890 | 0.28 | Binding ≤ 10μM |
GYRA-1-B | DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 9400 | 0.26 | Binding ≤ 10μM |
GYRB-1-B | DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial | Bacteria | 500 | 0.33 | Binding ≤ 10μM |
PARC-1-B | Topoisomerase IV Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 1200 | 0.31 | Binding ≤ 10μM |
GYRA-1-B | DNA Gyrase Subunit A (cluster #1 Of 1), Bacterial | Bacteria | 500 | 0.33 | Functional ≤ 10μM |
GYRB-1-B | DNA Gyrase Subunit B (cluster #1 Of 1), Bacterial | Bacteria | 500 | 0.33 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 500 | 0.33 | Binding ≤ 1μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 500 | 0.33 | Binding ≤ 1μM |
GYRA_MYCTU | Q07702 | DNA Gyrase Subunit A, Myctu | 9400 | 0.26 | Binding ≤ 10μM |
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 500 | 0.33 | Binding ≤ 10μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 500 | 0.33 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3890 | 0.28 | Binding ≤ 10μM |
PARC_STAAU | P0C1U9 | Topoisomerase IV Subunit A, Staau | 1200 | 0.31 | Binding ≤ 10μM |
GYRA_ECOLI | P0AES4 | DNA Gyrase Subunit A, Ecoli | 500 | 0.33 | Functional ≤ 10μM |
GYRB_ECOLI | P0AES6 | DNA Gyrase Subunit B, Ecoli | 500 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
Voltage gated Potassium channels |